Font:
AP

APLLTD / NSE / Biotechnology & Drugs

Alembic Pharmaceuticals

INR 821.676.10 (1.64%) 1D
Last updated: 2026-06-09T20:31:35.525916+00:00
Price Chart

1Y Price Trend

Open987.4
High1,107.9
Low635.8
Close731.5
Volume2,31,744
Change-255.9
Change %-25.92%

Key Information

Ticker SymbolAPLLTD
Current Price821.6
52-Week High1,044.8
52-Week Low635.8
Market Cap16,127.77
Beta0.93
Volume2,31,744
ISININE901L01018
Day High750
Day Low725.35
Open750

Recommendations

RatingBuy

Target High1,064.7

Target Low635.3

Target Mean2.22

Target Median52.78

Risk Metrics

Overall RiskBalanced risk

Board Risk32.81

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

Price to earnings forward of Alembic Pharmaceuticals Limited – NSE:APLLTD - TradingView3 days ago
Market news

Price to earnings forward of Alembic Pharmaceuticals Limited – NSE:APLLTD TradingView

Trade Spotlight: How should you trade Ather Energy, Alembic Pharma, GMR Airports, Gujarat Fluorochemicals, Mankind Pharma, and others on July 1? - TradingView9 days ago
Market news

Trade Spotlight: How should you trade Ather Energy, Alembic Pharma, GMR Airports, Gujarat Fluorochemicals, Mankind Pharma, and others on July 1? TradingView

Alembic Pharma Receives USFDA Approval for Generic Acne Treatment Dapsone Gel - Medical Dialogues10 days ago
Market news

Alembic Pharma Receives USFDA Approval for Generic Acne Treatment Dapsone Gel Medical Dialogues

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Dapsone Gel, 5% - IndiaMedToday10 days ago
Market news

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Dapsone Gel, 5% IndiaMedToday

Alembic Pharmaceuticals Secures USFDA Approval for Generic Dapsone Gel 5% - Machine Maker10 days ago
Market news

Alembic Pharmaceuticals Secures USFDA Approval for Generic Dapsone Gel 5% Machine Maker

Alembic Pharma Receives USFDA Approval for Generic Influenza Drug Tamiflu - Medical Dialogues11 days ago
Market news

Alembic Pharma Receives USFDA Approval for Generic Influenza Drug Tamiflu Medical Dialogues

Alembic Pharmaceuticals gets USFDA Final Approval for Oseltamivir Phosphate for Oral Suspension - IndiaMedToday12 days ago
Market news

Alembic Pharmaceuticals gets USFDA Final Approval for Oseltamivir Phosphate for Oral Suspension IndiaMedToday

Alembic Pharmaceuticals gets USFDA nod for Dapsone Gel - scanx.trade13 days ago
Market news

Alembic Pharmaceuticals gets USFDA nod for Dapsone Gel scanx.trade

FAQ

Stock FAQs

What is the NSE symbol for Alembic Pharmaceuticals?

Alembic Pharmaceuticals trades on NSE with the symbol APLLTD. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Alembic Pharmaceuticals share price and chart?

You can track Alembic Pharmaceuticals share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Alembic Pharmaceuticals?

Yes. ShareKeyX displays available financial statements for Alembic Pharmaceuticals using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Alembic Pharmaceuticals?

Yes. ShareKeyX displays available historical OHLC candles for Alembic Pharmaceuticals across supported chart ranges such as 7D, 1M, 3M, 6M and 1Y.

What sector or industry does Alembic Pharmaceuticals belong to?

Alembic Pharmaceuticals is classified under Biotechnology & Drugs in the available company data.

Does ShareKeyX show news for Alembic Pharmaceuticals?

Yes. ShareKeyX shows the latest available stock news for Alembic Pharmaceuticals from the connected stock news source.